Table 2.
Survival analysis between early and late-stage patient groups
| Tumor type | T | N | M | S |
|---|---|---|---|---|
| BRCA | p = 0.375 | p = 0.00012 | p = 0.008 | p = 0.0007 |
| COAD | p = 0.0011 | p = 0.011 | p = 1.48e-05 | p = 0.012 |
| HNSC | p = 0.051 | p = 0.0137 | p = 2.49e-07 | |
| KICH | p = 0.00896 | p = 0.00896 | ||
| KIRC | p = 2e-15 | p = 0.0125 | p = 0 | p = 0 |
| KIRP | p = 0.0043 | p = 0.005 | p = 8.86e-007 | |
| LUSC | p = 0.029 | p = 0.071 | p = 0.025 | |
| LUAD | p = 7.02e-09 | p = 3.26e-06 | p = 0.165 | p = 7.02e-09 |
| OV | p = 0.0537 | |||
| PRAD | p = 0.456 | p = 1 | ||
| SKCM | p = 0.418 | |||
| THCA | p = 0.324 | p = 0.597 | p = 2.49e-07 |